Business Context and Reporting Period
This Form 8-K reports on the results of Clarivate Plc's 2025 Annual General Meeting of Shareholders held on May 7, 2025. The filing was submitted on May 12, 2025. As of the record date (March 10, 2025), there were 688,956,113 ordinary shares outstanding. A quorum was established with 659,171,835 shares present in person or by proxy.
Key Financial Metrics
This filing is a current report regarding corporate governance and shareholder voting. It does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes and Voting Results
All five proposals presented to shareholders were approved. The voting results were as follows:
- Proposal 1 (Election of Directors): All 10 nominees were elected. Vote counts varied by nominee, with "For" votes ranging from approximately 595.6 million (Suzanne Heywood) to 626.8 million (Matitiahu Shem Tov). "Against" votes ranged from 1.2 million to 32.4 million.
- Proposal 2 (Executive Compensation): Approved with 619,205,075 votes "For" and 8,950,331 votes "Against".
- Proposal 3 (Auditor Ratification): PricewaterhouseCoopers LLP was reappointed with 645,344,218 votes "For" and 2,868,670 votes "Against".
- Proposal 4 (Incentive Award Plan): The Amended and Restated 2019 Incentive Award Plan was approved with 558,462,654 votes "For" and 69,708,837 votes "Against".
- Proposal 5 (Share Repurchase Authorization): Shareholders authorized open-market repurchases of ordinary shares. The special resolution passed with 627,212,208 votes "For" and 676,681 votes "Against".
Guidance, Outlook, and Other Events
The Company announced that the 2026 Annual General Meeting of Shareholders is scheduled for May 14, 2026. Further details regarding this future meeting will be provided in the subsequent proxy statement. No specific financial guidance, management commentary on operations, or discussion of risks and contingencies is included in this filing.
Investor Verification Checklist
- Verify the specific number of shares voted "Against" for each director nominee, particularly Suzanne Heywood and Andrew Snyder, who received the highest dissenting votes.
- Confirm the total number of shares authorized for repurchase under Proposal 5, as the filing confirms authorization but does not specify the dollar limit or share cap in the text provided.
- Review the definitive proxy statement dated March 28, 2025, for detailed executive compensation data referenced in Proposal 2.
- Check the upcoming proxy statement for the 2026 Annual General Meeting for any changes to the board composition or corporate governance policies.